v3 Template
M

MitoRx Therapeutics

Biotechnology / Healthcare ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$5.1M
Funding Rounds
1
Last Funding
2023-12-13

About MitoRx Therapeutics

MitoRx Therapeutics is a UK-based biotech company focused on developing revolutionary mitochondrial-targeted therapeutics to address challenging diseases. Their mission is to arrest or delay progressive diseases by restoring sulfide-mediated protective metabolism, initially targeting obesity-related indications and myopathies, with potential expansion to broader medical areas.

Products & Services

mtH2SD Technology:A first-in-class mitochondrial-targeted sulfide donor platform that reverses mitochondrial dysfunction in progressive diseases, focusing on restoring sulfide-signaling through protein S-persulfidation. It targets diseases like obesity-related conditions and Duchenne muscular dystrophy.
Pipeline Programs:A pipeline of pre-clinical small molecule drugs for diseases involving mitochondrial dysfunction, with potential applications in lung inflammatory diseases, neurodegenerative disorders (Parkinson's, Alzheimer's, Huntington's), and muscle wasting conditions (sarcopenia, cancer cachexia, COPD cachexia).

Specialties

Mitochondrial-targeted therapeutics Sulfide-signaling restoration Metabolic disease treatment Myopathy treatment Small molecule drug discovery Obesity-related indications Neurodegenerative disease research Muscle wasting prevention

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed Extension
T: -
FT: Seed Extension
A: 5080000
MR: -
FA: £4m
FAN: 5080000
D: 2023-12-13
FD: 2023-12-13
7 investors
Seed Extension Latest
2023-12-13
$5.1M
7 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Chas Bountra

Pro-Vice Chancellor for Innovation and Professor of Translational Medicine at the University of Oxford

R

Rury Holman

Emeritus Professor of Diabetic Medicine

K

Kay Davies

Dr Lee's Professor of Anatomy Emeritus

L

Laurent Servais

Professor of Paediatric Neuromuscular Disease and Professor of Child Neurology

B

Bernd C Schwahn

Consultant in Paediatric Metabolic Medicine

C

Caroline Le Guiner

Preclinical Expert and Team Leader

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

MitoRx Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~480 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro